Current advances in understanding of immunopathology of atherosclerosis

Virchows Archiv

Volumn 458, Issue 2, 2011, Pages 117-123

  Perrins, Colin John ^a   Bobryshev, Yuri V ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Arteries; Atherogenesis; Dendritic cells; Immune inflammation; Natural killer T cells

Indexed keywords

INTERLEUKIN 10; TOLL LIKE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ANTIGEN PRESENTATION; ATHEROSCLEROSIS; CD4+ CD25+ T LYMPHOCYTE; CELL ACTIVATION; CELL FUNCTION; CELL THERAPY; CELLULAR DISTRIBUTION; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE COURSE; HUMAN; IMMUNOPATHOLOGY; IMMUNOTHERAPY; INNATE IMMUNITY; NATURAL KILLER T CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW;

ANIMALS; ANTIGEN PRESENTATION; ATHEROSCLEROSIS; DENDRITIC CELLS; HUMANS; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 79951720826     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-010-1006-5     Document Type: Review

References (79)

1. L Jonasson J Holm O Skalli G Bondjers GK Hansson 1986 Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque Arteriosclerosis 6 131 138 1:STN:280:DyaL287lvVCqsA%3D%3D 2937395 (Pubitemid 16024121)
2. GK Hansson J Holm L Jonasson 1989 Detection of activated T lymphocytes in the human atherosclerotic plaque Am J Pathol 135 169 175 1:STN:280: DyaL1MzntF2gsg%3D%3D 2505620 (Pubitemid 19229001)
3. GK Hansson L Jonasson 2009 The discovery of cellular immunity in the atherosclerotic plaque Arterioscler Thromb Vasc Biol 29 1714 1717 1:CAS:528:DC%2BD1MXht1ynu7nJ 10.1161/ATVBAHA.108.179713 19846836
4. GK Hansson 2009 Atherosclerosis-an immune disease: the Anitschkov Lecture 2007 Atherosclerosis 202 2 10 1:CAS:528:DC%2BD1cXhsFajsb%2FP 10.1016/j.atherosclerosis.2008.08.039 18951547
5. X Zhou A Nicoletti R Elhage GK Hansson 2000 Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice Circulation 102 2919 2922 1:CAS:528:DC%2BD3MXitlWguw%3D%3D 11113040
6. H Ait-Oufella BL Salomon S Potteaux AK Robertson P Gourdy J Zoll R Merval B Esposito JL Cohen S Fisson RA Flavell GK Hansson D Klatzmann A Tedgui Z Mallat 2006 Natural regulatory T cells control the development of atherosclerosis in mice Nat Med 12 178 180 1:CAS:528:DC%2BD28XhtFWqtbY%3D 10.1038/nm1343 16462800 (Pubitemid 43214743)
7. Z Mallat A Gojova V Brun B Esposito N Fournier F Cottrez A Tedgui H Groux 2003 Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice Circulation 108 1232 1237 1:CAS:528:DC%2BD3sXmvFSitL4%3D 10.1161/01.CIR.0000089083.61317.A1 12912803 (Pubitemid 37099993)
8. A Mor D Planer G Luboshits A Afek S Metzger T Chajek-Shaul G Keren J George 2007 Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis Arterioscler Thromb Vasc Biol 27 893 900 1:CAS:528:DC%2BD2sXislCrs7Y%3D 10.1161/01.ATV.0000259365.31469.89 17272749 2007 (Pubitemid 46606722)
9. S Whitham T Ramsamy 2006 articipatory role of natural killer and natural killer T cells in atherosclerosis: lessons learned from in vivo mouse studies Canad J Physiol Pharmacol 84 67 75 10.1139/Y05-159 (Pubitemid 44011952)
10. YV Bobryshev RS Lord 1995 Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of vascular dendritic cells in athero-resistant and athero-prone areas of the normal aorta Arch Histol Cytol 58 307 322 1:STN:280:DyaK28%2FotFSltQ%3D%3D 10.1679/aohc.58.307 8527238
11. YV Bobryshev RS Lord 1998 Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions Cardiovasc Res 37 799 810 1:CAS:528:DyaK1cXivVKmtLs%3D 10.1016/S0008-6363(97)00229-0 9659465 (Pubitemid 28231176)
12. YV Bobryshev 2010 Dendritic cells and their role in atherogenesis Lab Invest 90 970 984 10.1038/labinvest.2010.94 20458277
13. G Stoll M Bendszus 2006 Inflammation and atherosclerosis: novel insights into plaque formation and destabilization Stroke 37 1923 1932 1:CAS:528:DC%2BD28XmtVShu7c%3D 10.1161/01.STR.0000226901.34927.10 16741184 (Pubitemid 44297753)
14. R Ross 1993 The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 362 801 809 1:CAS:528:DyaK3sXktVGqu7c%3D 10.1038/362801a0 8479518 (Pubitemid 23132154)
15. RS Lord YV Bobryshev 2002 Hallmarks of atherosclerotic lesion development with special reference to immune inflammatory mechanisms Cardiovasc Surg 10 405 414 1:STN:280:DC%2BD38vpslOisA%3D%3D 10.1016/S0967-2109(02)00039-X 12359417 (Pubitemid 35299943)
16. G Millonig C Schwentner P Mueller C Mayerl G Wick 2001 The vascular-associated lymphoid tissue: a new site of local immunity Curr Opin Lipidol 12 547 553 1:CAS:528:DC%2BD3MXnslGjsL4%3D 10.1097/00041433-200110000- 00011 11561175 (Pubitemid 32980304)
17. G Wick M Knoflach Q Xu 2004 Autoimmune and inflammatory mechanisms in atherosclerosis Annu Rev Immunol 22 361 403 1:CAS:528:DC%2BD2cXktlOgs7Y%3D 10.1146/annurev.immunol.22.012703.104644 15032582 (Pubitemid 38680427)
18. YV Bobryshev 2006 Monocyte recruitment and foam cell formation in atherosclerosis Micron 37 208 222 1:CAS:528:DC%2BD28XoslKnsg%3D%3D 10.1016/j.micron.2005.10.007 16360317 (Pubitemid 43106595)
19. A Niessner JJ Goronzy CM Weyand 2007 Immune-mediated mechanisms in atherosclerosis: prevention and treatment of clinical manifestations Curr Pharm Des 13 3701 3710 1:CAS:528:DC%2BD1cXitVSlt70%3D 10.2174/138161207783018626 18220809
20. R Steinman J Adams Z Cohn 1973 Identification of a novel cell type in peripheral lymphoid organs of mice, morphology, quantitation, tissue distribution J Exp Med 137 1142 1162 1:STN:280:DyaE3s7ntFejsw%3D%3D 10.1084/jem.137.5.1142 4573839
21. Lotze M, Thomson A (2001) Dendritic cells: biology and clinical applications, Ed 2nd edn. Academic, San Diego, California, USA
22. YV Bobryshev 2005 Dendritic cells in atherosclerosis: current status of the problem and clinical relevance Eur Heart J 26 1700 1704 10.1093/eurheartj/ ehi282 15855191 (Pubitemid 41219842)
23. J Jongstra-Bilen M Haidari SN Zhu M Chen D Guha MI Cybulsky 2006 Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis J Exp Med 203 2073 2083 1:CAS:528: DC%2BD28XptlSgs7w%3D 10.1084/jem.20060245 16894012 (Pubitemid 44352229)
24. JH Choi Y Do C Cheong H Koh SB Boscardin YS Oh L Bozzacco C Trumpfheller CG Park RM Steinman 2009 Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves J Exp Med 206 479 505 10.1084/jem.20082129
25. GJ Randolph S Potteaux 2010 Vascular dendritic cells as gatekeepers of lipid accumulation within nascent atherosclerotic plaques Circ Res 106 227 229 1:CAS:528:DC%2BC3cXhsVyhsb8%3D 10.1161/CIRCRESAHA.109.212191 20133906
26. M Lipscomb B Masten 2002 Dendritic cells: immune regulators in health and disease Physiol Rev 82 97 130 1:CAS:528:DC%2BD38XovFSisA%3D%3D 11773610 (Pubitemid 34654216)
27. R Steinman D Hawiger M Nussenzweig 2003 Tolerogenic dendritic cells Ann Rev Immunol 21 685 711 1:CAS:528:DC%2BD3sXjtF2is7g%3D 10.1146/annurev.immunol. 21.120601.141040 (Pubitemid 37174545)
28. W Heath G Belz G Behrens 2004 Cross-presentation, dendritic cell subsets and the generation of immunity to cellular agents Immunol Rev 199 9 26 1:CAS:528:DC%2BD2cXltFygs7s%3D 10.1111/j.0105-2896.2004.00142.x 15233723 (Pubitemid 38736761)
29. E de Jong H Smits M Kapsenberg 2005 Dendritic cell-mediated T cell polarization Springer Semin Immunopathol 26 289 307 10.1007/s00281-004-0167-1 15609003
30. C Gelin I Sloma D Charron N Mooney 2006 Regulation of MHC II and CD1 antigen presentation: from ubiquity to security J Leukoc Biol 85 215 224 10.1189/jlb.0308206 2009
31. A Niessner C Weyland 2009 Dendritic cells in atherosclerotic disease Clin Immunol 134 25 32 10.1016/j.clim.2009.05.006 19520615
32. YV Bobryshev T Taksir RS Lord MW Freeman 2001 Evidence that dendritic cells infiltrate atherosclerotic lesions in apolipoprotein E-deficient mice Histol Histopathol 16 801 808 1:STN:280:DC%2BD3MvmsFGmsw%3D%3D 11510970 (Pubitemid 32700390)
33. J Ozmen YV Bobryshev RS Lord KW Ashwell 2002 Identification of dendritic cells in aortic atherosclerotic lesions in rats with diet-induced hypercholesterolaemia Histol Histopathol 17 223 237 1:STN:280: DC%2BD38%2FptFehtg%3D%3D 11820216 (Pubitemid 34116426)
34. RM Steinman D Hawiger K Liu L Bonifaz D Bonnyay K Mahnke T Iyoda J Ravetch M Dhodapkar K Inaba M Nussenzweig 2003 Dendritic cell function in vivo during the steady state: a role in peripheral tolerance Ann NY Acad Sci 987 15 25 1:CAS:528:DC%2BD3sXksFSlsrs%3D 10.1111/j.1749-6632.2003.tb06029.x 12727620 (Pubitemid 36584003)
35. SH Naik D Metcalf A van Nieuwenhuijze I Wicks L Wu M O'Keeffe K Shortman 2006 Intrasplenic steady-state dendritic cell precursors that are distinct from monocytes Nat Immunol 7 663 671 1:CAS:528:DC%2BD28Xksleksbo%3D 10.1038/ni1340 16680143 (Pubitemid 43797348)
36. K Shortman S Naik 2007 Steady-state and inflammatory dendritic cell development Nat Rev Immunol 7 19 1:CAS:528:DC%2BD28XhtlCht7fF 10.1038/nri1996 17170756 (Pubitemid 46020824)
37. H Ueno E Klechevsky R Morita C Aspord T Cao T Matsui T Di Pucchio J Connolly JW Fay V Pascual AK Palucka J Banchereau 2007 Dendritic cell subsets in health and disease Immunol Rev 219 118 142 1:CAS:528:DC%2BD2sXht1Cnt7zI 10.1111/j.1600-065X.2007.00551.x 17850486 (Pubitemid 47393528)
38. NS Wilson D El-Sukkari GT Belz CM Smith RJ Steptoe WR Heath K Shortman JA Villadangos 2003 Most lymphoid organ dendritic cell types are phenotypically and functionally immature Blood 102 2187 2194 1:CAS:528:DC%2BD3sXntlKrs7k%3D 10.1182/blood-2003-02-0513 12791652 (Pubitemid 37122397)
39. C Auffray M Sieweke F Geissmann 2003 Blood monocytes: development, heterogeneity, and relationship with dendritic cells Ann Rev Immunol 27 669 692 10.1146/annurev.immunol.021908.132557
40. EL Gautier T Huby F Saint-Charles B Ouzilleau J Pirault V Deswaerte F Ginhoux ER Miller JL Witztum MJ Chapman P Lesnik 2009 Conventional dendritic cells at the crossroads between immunity and cholesterol homeostasis in atherosclerosis Circulation 119 2367 2375 1:CAS:528:DC%2BD1MXltV2jsrc%3D 10.1161/CIRCULATIONAHA.108.807537 19380622
41. L Wang D Li K Yang Y Hu Q Zeng 2008 Toll-like receptor 4 and mitogen-activated protein kinase signal system are involved in activation of dendritic cells in patients with acute coronary syndrome Immunology 125 122 130 1:CAS:528:DC%2BD1cXhtVCrtrrJ 10.1111/j.1365-2567.2008.02827.x 18373609
42. KE Paulson SN Zhu M Chen S Nurmohamed J Jongstra-Bilen MI Cybulsky 2010 Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis Circ Res 106 383 390 1:CAS:528: DC%2BC3cXhsVyhtLo%3D 10.1161/CIRCRESAHA.109.210781 19893012
43. B Ludewig S Freigang M Jäggi MO Kurrer YC Pei L Vlk B Odermatt RM Zinkernagel H Hengartner 2000 Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model Proc Natl Acad Sci USA 97 12752 12757 1:CAS:528:DC%2BD3cXotFyntLo%3D 10.1073/pnas.220427097 11050173
44. V Angeli J Llodrá JX Rong K Satoh S Ishii T Shimizu EA Fisher GJ Randolph 2004 Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilisation Immunity 21 561 574 1:CAS:528: DC%2BD2cXpvVygtLs%3D 10.1016/j.immuni.2004.09.003 15485633 (Pubitemid 39370511)
45. RR Packard E Maganto-García I Gotsman I Tabas P Libby AH Lichtman 2008 CD11c(+) dendritic cells maintain antigen processing presentation capabilities and CD4(+) T-cell priming efficacy under hypercholesterolemia conditions Circ Res 103 965 973 1:CAS:528:DC%2BD1cXht1CqtrjF 10.1161/CIRCRESAHA.108.185793 18832748
46. KL Habets GH van Puijvelde LM van Duivenvoorde EJ van Wanrooij P de Vos JW Tervaert TJ van Berkel RE Toes J Kuiper 2010 Vaccination using oxidised low-density lipoproteins-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice Cardiovasc Res 85 622 630 1:CAS:528: DC%2BC3cXkt1egtg%3D%3D 10.1093/cvr/cvp338 19819882
47. C Hjerpe D Johansson A Hermansson GK Hansson X Zhou 2010 Dendritic cells pulsed with melondialdehyde modified low density lipoprotein aggravate atherosclerosis in ApoE (-/-) mice Atherosclerosis 209 436 441 1:CAS:528:DC%2BC3cXjvF2ku74%3D 10.1016/j.atherosclerosis.2009.10.003 19897195
48. T van Es GH van Puijvelde AC Foks KL Habets I Bot E Gilboa TJ Van Berkel J Kuiper 2010 Vaccination against Foxp3(+) regulatory T cells aggravates atherosclerosis Atherosclerosis 209 74 80 10.1016/j.atherosclerosis.2009.08.041 19765709
49. CJ Alderman PR Bunyard BM Chain JC Foreman DS Leake DR Katz 2002 Effects of oxidised low density lipoprotein on dendritic cells: a possible immunoregulatory component of the atherogenic micro-environment? Cardiovasc Res 55 806 819 1:CAS:528:DC%2BD38XmtlCqtbw%3D 10.1016/S0008-6363(02)00447-9 12176130
50. P Matzinger 2007 Friendly and dangerous signals: is the tissue in control? Nat Immunol 8 11 13 1:CAS:528:DC%2BD28Xhtlaqs7bF 10.1038/ni0107-11 17179963 (Pubitemid 46242350)
51. TM Doherty EA Fisher M Arditi 2006 TLR signaling and trapped vascular dendritic cells in the development of atherosclerosis Trends Immunol 27 222 227 1:CAS:528:DC%2BD28XktVyit74%3D 10.1016/j.it.2006.03.006 16580258
52. A Bendelac PB Savage L Teyton 2007 The biology of NKT cells Annu Rev Immunol 25 297 336 1:CAS:528:DC%2BD2sXltlansr4%3D 10.1146/annurev.immunol.25. 022106.141711 17150027 2007 (Pubitemid 46697911)
53. C Erbel K Sato FB Meyer SL Kopecky RL Frye JJ Goronzy CM Weyand 2007 Functional profile of activated dendritic cells in unstable atherosclerotic plaque Basic Res Cardiol 102 123 132 1:CAS:528:DC%2BD2sXjs1Wis70%3D 10.1007/s00395-006-0636-x 17136419 (Pubitemid 46189953)
54. A Yilmaz M Lochno F Traeg I Cicha C Reiss C Stumpf D Raaz T Anger K Amann T Probst J Ludwig WG Daniel CD Garlichs 2004 Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques Atherosclerosis 176 85 93 10.1016/j.atherosclerosis.2003.10.002 (Pubitemid 38058605)
55. C Asselin-Paturel G Trinchieri 2005 Production of type I interferons: plasmacytoid dendritic cells and beyond J Exp Med 202 461 465 1:CAS:528:DC%2BD2MXosVaku7Y%3D 10.1084/jem.20051395 16103406 (Pubitemid 41186943)
56. T Decker M Muller S Stockinger 2005 The yin and yang of type I interferon activity in bacterial infection Nat Rev Immunol 5 675 687 1:CAS:528: DC%2BD2MXpslakuro%3D 10.1038/nri1684 16110316 (Pubitemid 43086170)
57. EA Van Vré VY Hoymans H Bult M Lenjou DR Van Bockstaele CJ Vrints JM Bosmans 2006 Decreased number of circulating plasmacytoid dendritic cells in patients with atherosclerotic coronary artery disease Coron Artery Dis 17 243 248 10.1097/00019501-200605000-00007 16728874 (Pubitemid 44324834)
58. YV Bobryshev RS Lord 2005 Co-accumulation of dendritic cells and natural killer T cells within rupture-prone regions in human atherosclerotic plaques J Histochem Cytochem 53 781 785 1:CAS:528:DC%2BD2MXltVKltrw%3D 10.1369/jhc.4B6570.2005 15928327 (Pubitemid 40726958)
59. T Lee H Yen C Pan L Chau 1999 The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice Atheroscler Thromb Vasc Biol 19 734 742 1:CAS:528:DyaK1MXitFGnsbY%3D (Pubitemid 29135179)
60. P Davenport P Tipping 2003 The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice Am J Pathol 163 1117 1125 1:CAS:528:DC%2BD3sXnsVCisrc%3D 10.1016/S0002-9440(10)63471- 2 12937153 (Pubitemid 37040147)
61. G Caligiuri M Rudling V Ollivier MP Jacob JB Michel GK Hansson A Nicoletti 2003 Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice Mol Med 9 10 17 1:CAS:528:DC%2BD3sXls1CisL8%3D 12765335 (Pubitemid 36667687)
62. L Pinderski A Fyfe C Hedrick T Olvera 1999 Interleukin-10 blocks atherosclerotic events in vitro and in vivo Atheroscler ThrombVasc Biol 19 2847 2853 (Pubitemid 30029809)
63. A Aslanian H Chapman I Charo 2005 Transient role for CD1d-restricted natural killer T cells in the formation of atherosclerotic lesions Atheroscler ThrombVasc Biol 25 628 632 1:CAS:528:DC%2BD2MXhtl2ktb4%3D 10.1161/01.ATV. 0000153046.59370.13 (Pubitemid 40315689)
64. SC Whitman DL Rateri SJ Szilvassy W Yokoyama A Daugherty 2004 Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice Arterioscler Thromb Vasc Biol 24 1049 1054 1:CAS:528:DC%2BD2cXkt1Ogtr0%3D 10.1161/01.ATV.0000124923.95545.2c 14988092 (Pubitemid 38737830)
65. L Van Kaer 2007 NKT cells: T lymphocytes with innate effector functions Curr Opin Immunol 19 354 364 10.1016/j.coi.2007.03.001 17428648 (Pubitemid 46687006)
66. JS Bezbradica AK Stanic N Matsuki H Bour-Jordan JA Bluestone JW Thomas D Unutmaz L Van Kaer S Joyce 2005 Distinct roles of dendritic cells and B cells in Va14Ja18 natural T cell activation in vivo J Immunol 174 4694 4705
67. J Schmieg G Yang RW Franck N Van Rooijen M Tsuji 2005 Glycolipid presentation to natural killer T cells differs in an organ-dependent fashion Proc Natl Acad Sci USA 102 1127 1132 1:CAS:528:DC%2BD2MXhtFCitrs%3D 10.1073/pnas.0408288102 15644449 (Pubitemid 40170737)
68. L Van Kaer 2004 Natural killer T cells as targets for immunotherapy of autoimmune diseases Immunol Cell Biol 82 315 322 10.1111/j.0818-9641.2004.01252. x 15186263 (Pubitemid 38870026)
69. G Hansson J Nilsson 2009 Vaccination against atherosclerosis? Induction of atheroprotective immunity Semin Immunopathol 31 95 101 1:CAS:528: DC%2BD1MXntVWjt70%3D 10.1007/s00281-009-0151-x 19468734
70. W Palinski E Milller J Witztum 1995 Immunisation of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis Proc Natl Acad Sci USA 92 821 825 1:CAS:528:DyaK2MXjsVKiurg%3D 10.1073/pnas.92.3.821 7846059
71. CJ Binder K Hartvigsen JL Witztum 2007 Promise of immune modulation to inhibit atherogenesis J Am Coll Cardiol 50 547 550 10.1016/j.jacc.2007.04.054 17678739 (Pubitemid 47126778)
72. J Nilsson G Nordin Fredrikson A Schiopu PK Shah B Jansson R Carlsson 2007 Oxidized LDL antibodies in treatment and risk assessment of atherosclerosis and associated cardiovascular disease Curr Pharm Des 13 1021 1030 1:CAS:528:DC%2BD2sXmtVWmu7o%3D 10.2174/138161207780487557 17430165 (Pubitemid 46696558)
73. GN Fredrikson H Björkbacka I Söderberg I Ljungcrantz J Nilsson 2008 Treatment with apo B peptide vaccines inhibits atherosclerosis in human apo B-100 transgenic mice without inducing an increase in peptide-specific antibodies J Intern Med 264 563 570 1:CAS:528:DC%2BD1MXmtVSjsg%3D%3D 10.1111/j.1365-2796.2008.01995.x 18783480
74. M van Leeuwen J Damoiseaux A Duijvestijn JW Tervaert 2009 The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis Autoimmun Rev 9 53 57 10.1016/j.autrev.2009.03.001 19285155
75. YV Bobryshev 2001 Can dendritic cells be exploited for therapeutic intervention in atherosclerosis? Atherosclerosis 154 511 512 1:CAS:528:DC%2BD3MXhsVamu78%3D 10.1016/S0021-9150(00)00692-4 11263414 (Pubitemid 32146628)
76. M Markiewicz W Kast 2004 Progress in the development of immunotherapy of cancer using ex vivo-generated dendritic cells expressing multiple tumor antigen epitopes Cancer Investig 22 417 434 1:CAS:528:DC%2BD2cXmvF2ju70%3D 10.1081/CNV-200029072 (Pubitemid 39310912)
77. P Dubsky H Ueno B Piqueras J Connolly J Banchereau AK Palucka 2005 Human dendritic cell subsets for vaccination J Clin Immunol 25 551 572 10.1007/s10875-005-8216-7 16380819 (Pubitemid 43011747)
78. S Benko Z Magyarics A Szabó E Rajnavölgyi 2008 Dendritic cell subtypes as primary targets of vaccines: the emerging role and cross-talk of pattern recognition receptors Biol Chem 389 469 485 1:CAS:528: DC%2BD1cXls1aitrk%3D 10.1515/BC.2008.054 18953714 (Pubitemid 351874188)
79. RM Steinman 2008 Dendritic cells in vivo: a key target for a new vaccine science Immunity 29 319 324 1:CAS:528:DC%2BD1cXhtF2jtLvI 10.1016/j.immuni.2008. 08.001 18799140